Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 5/2019

01-05-2019 | Irritable Bowel Syndrome | Concise Commentary

Concise Commentary: Bloating Makes a Comeback in IBS

Author: Giuseppe Chiarioni

Published in: Digestive Diseases and Sciences | Issue 5/2019

Login to get access

Excerpt

Bloating and abdominal distension are bothersome symptoms of ambiguous etiology frequently reported by patients with functional gastrointestinal disorders (FGID) [1]. While noticeable abdominal bloating was originally included in the Manning criteria to diagnose irritable bowel syndrome (IBS), the Rome criteria has shifted the attention to abdominal pain [2]. Nevertheless, the majority (60%) of IBS patients score bloating as their most bothersome symptom [3]. Moreover, the prevalence of bloating in FGID is ill-defined for a number of studies that do not rely on standardized diagnostic criteria [1, 4]. …
Literature
1.
Iovino P, Bucci C, Tremolaterra F, et al. Bloating and functional gastro-intestinal disorders: where are we and where are we going? World J Gastroenterol. 2014;20:14407–14419.CrossRefPubMedPubMedCentral
2.
Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480–1491.CrossRefPubMed
3.
Sach J, Bolus R, Fitzgerald L, et al. Is there a difference between abdominal pain and discomfort in moderate to severe IBS patients? Am J Gastroenterol. 2002;97:3131–3138.CrossRefPubMed
4.
5.
Metadata
Title
Concise Commentary: Bloating Makes a Comeback in IBS
Author
Giuseppe Chiarioni
Publication date
01-05-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 5/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5439-z

Other articles of this Issue 5/2019

Digestive Diseases and Sciences 5/2019 Go to the issue

Original Article

Patient Satisfaction and Healthcare Utilization Using Telemedicine in Liver Transplant Recipients

Correction

Correction to: Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California

Editorial

Under Pressure: Do Volume-Based Measurements Define Rectal Hyposensitivity in Clinical Practice?

Original Article

Presumed Consent: A Potential Tool for Countries Experiencing an Organ Donation Crisis

Original Article

Inhibition of IκB Kinase 2 Attenuated the Proliferation and Induced Apoptosis of Gastric Cancer

Original Article

Significant Morbidity and Mortality Associated with Fecal Impaction in Patients Who Present to the Emergency Department
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits